Human induced pluripotent stem cell-derived cardiac fibroblasts (iPSC-cFBs) provide a renewable stromal cell source for studies of cardiac fibrosis and cardiomyocyte–fibroblast interactions. The authors reported that expansion on conventional tissue-culture polystyrene (TCP) produced passage-dependent changes in basal phenotype. Projected cell area increased with passage. Expression of alpha-SMA, a commonly used marker associated with fibroblast-to-myofibroblast transition (FMT), also rose across passages. These two observations—larger spread area and elevated alpha-SMA—served as early indications that serial expansion on stiff plastic promotes a phenotype shift toward myofibroblast-like features. The abstract did not provide specific numeric effect sizes, exact passage numbers, or culture durations; readers should consult the full text for detailed methods and quantitative results.
Investigators compared PDMS substrates of differing stiffness—reported as 15 kPa and 2 MPa in the abstract—during iPSC-cFB derivation and expansion. Across two independent differentiation protocols, mechanical culture history influenced both basal phenotypes and responsiveness to TGF-beta1. Data indicated that substrate stiffness during derivation and expansion altered how cells responded to a canonical profibrotic cue. The study team observed that these effects were dependent on passage number, meaning that early and later passages showed different baseline states and signaling responsiveness depending on prior mechanical exposure. The abstract does not itemize the specific assays used to quantify TGF-beta1 responses, nor does it include kinetic or dose–response data; the main manuscript and supplementary material likely contain those methodological details.
The authors noted a divergence between outcomes measured after replating cells onto two-dimensional substrates and collective responses observed in three-dimensional tissues. In other words, mechanical history influenced TGF-beta1 responses in 3D cultures in ways that were not predictable from 2D replating experiments. This indicates that fibroblast-autonomous remodeling measured within a tissue context can reflect history-dependent behavior that two-dimensional assays may fail to capture. The abstract emphasizes that three-dimensional remodeling reads out collective behaviors shaped by prior mechanical exposure, but it does not report specific remodeling metrics—such as compaction, matrix deposition, or mechanical properties—in the abstract itself.
Importantly, the study team observed that mechanical culture history did not irreversibly determine fibroblast state. Subsequent passage and changes in microenvironmental conditions were sufficient to attenuate or re-express history-dependent phenotypes. This suggests phenotypic plasticity in iPSC-cFBs: prior mechanical cues modulate cellular programs, but later culture conditions can overwrite or reinstate those programs. The authors framed this as evidence supporting the flexible use of iPSC-cFBs for basic biological investigations and tissue engineering workflows that require scalable cell numbers while retaining controllable phenotype.
Limitations and unanswered questions documented in the abstract
The article is a preprint and has not been certified by peer review. The abstract does not include detailed experimental parameters—such as passage numbers, exact timelines, culture media composition, or quantitative assay readouts—so interpretation of effect magnitude and reproducibility requires the full methods and supplementary files. The source reports that mechanical history affects phenotype and responsiveness but does not claim irreversible fate commitment; how long history-dependent states persist under varied in vitro or in vivo–like conditions remains an open question within the abstract. The authors did not report translational studies or in vivo validation in this summary. Readers should refer to the full manuscript for comprehensive methods, numerical results, and any additional limitations discussed by the investigators.
Funding and disclosure
The abstract lists support from the National Heart, Lung, and Blood Institute (R01HL159094, R01HL170079) and the U.S. National Science Foundation (award 2338931). The authors declared no competing interests in the preprint metadata. As with all preprints, findings should be interpreted as preliminary until peer review is complete.